Receptors, Dopamine D2DopamineReceptors, Dopamine D1Receptors, Dopamine D3Dopamine AgonistsDopamine AntagonistsReceptors, Dopamine D4Receptors, DopamineReceptors, Dopamine D5Dopamine AgentsDopamine Plasma Membrane Transport ProteinsBenzazepinesQuinpiroleRacloprideCorpus StriatumSalicylamidesDopamine Uptake InhibitorsSulpirideSpiperoneHaloperidolApomorphineNucleus AccumbensDopamine beta-Hydroxylase2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineNeostriatumCocaineDomperidoneDopamine and cAMP-Regulated Phosphoprotein 32AmphetamineRats, Sprague-DawleyTetrahydronaphthalenesErgolinesLevodopaBehavior, AnimalCatalepsyMotor ActivityAntipsychotic AgentsBromocriptinePyrrolidinesDopaminergic NeuronsTyrosine 3-MonooxygenaseCaudate NucleusHomovanillic AcidMicrodialysisSubstantia NigraButaclamolOxidopaminePutamenVentral Tegmental AreaDose-Response Relationship, DrugNeuronsClozapineRadioligand AssayYawningMethamphetamineBrainPrefrontal CortexRewardMesencephalonFlupenthixolalpha-MethyltyrosinePiperazinesConditioning, OperantDihydroxyphenylalanineBasal GangliaCocaine-Related DisordersTropanesReceptor, Adenosine A2ACentral Nervous System StimulantsRats, WistarHyperkinesisDyskinesia, Drug-InducedMSH Release-Inhibiting HormonePositron-Emission TomographyStereotyped BehaviorVesicular Monoamine Transport ProteinsPergolideLimbic SystemBenzamidesParkinson Disease, SecondaryAnalysis of VarianceBiogenic MonoaminesReserpineDrug InteractionsSynaptic TransmissionNomifensineLisurideSerotoninBrain ChemistryAntiparkinson AgentsAutoradiographyParkinsonian DisordersSchizophreniaOxazinesFenoldopamCarbon RadioisotopesReinforcement (Psychology)Mice, KnockoutNerve Tissue ProteinsStartle Reaction